false --12-31 Q2 0000891417 0000891417 2024-01-01 2024-06-30 0000891417 2024-08-19 0000891417 2024-04-01 2024-06-30 0000891417 2023-04-01 2023-06-30 0000891417 2023-01-01 2023-06-30 0000891417 2024-06-30 0000891417 2023-12-31 0000891417 us-gaap:NonrelatedPartyMember 2024-06-30 0000891417 us-gaap:NonrelatedPartyMember 2023-12-31 0000891417 us-gaap:RelatedPartyMember 2024-06-30 0000891417 us-gaap:RelatedPartyMember 2023-12-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-03-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000891417 us-gaap:RetainedEarningsMember 2024-03-31 0000891417 2024-03-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-03-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000891417 us-gaap:RetainedEarningsMember 2023-03-31 0000891417 2023-03-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-12-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000891417 us-gaap:RetainedEarningsMember 2023-12-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000891417 us-gaap:RetainedEarningsMember 2022-12-31 0000891417 2022-12-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-04-01 2024-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000891417 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000891417 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-01-01 2024-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0000891417 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0000891417 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000891417 us-gaap:RetainedEarningsMember 2024-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000891417 us-gaap:RetainedEarningsMember 2023-06-30 0000891417 2023-06-30 0000891417 NMGX:AppliedNanotechIncMember 2024-01-01 2024-06-30 0000891417 us-gaap:ConvertibleDebtMember 2022-01-07 0000891417 us-gaap:ConvertibleDebtMember 2022-01-07 2022-01-07 0000891417 us-gaap:ConvertibleDebtMember 2022-01-26 0000891417 us-gaap:ConvertibleDebtMember 2022-01-31 0000891417 NMGX:ConvertibleDebtOneMember 2022-01-26 2022-01-26 0000891417 NMGX:ConvertibleDebtTwoMember 2022-01-31 2022-01-31 0000891417 NMGX:ConvertibleDebtOneMember 2022-01-26 0000891417 NMGX:ConvertibleDebtTwoMember 2022-01-26 0000891417 NMGX:ConvertibleDebtThreeMember 2022-01-31 0000891417 NMGX:ConvertibleDebtTwoMember 2022-01-31 0000891417 NMGX:ConvertibleDebtThreeMember 2022-02-14 0000891417 us-gaap:ConvertibleDebtMember 2022-07-27 0000891417 NMGX:ConvertibleDebtOneMember 2022-07-27 0000891417 NMGX:ConvertibleDebtOneMember us-gaap:RelatedPartyMember 2022-07-27 0000891417 us-gaap:ConvertibleDebtMember 2022-08-22 0000891417 us-gaap:ConvertibleDebtMember 2022-08-19 2022-08-22 0000891417 us-gaap:ConvertibleDebtMember 2022-10-24 2022-10-26 0000891417 us-gaap:ConvertibleDebtMember 2022-10-26 0000891417 us-gaap:ConvertibleDebtMember 2023-10-18 2023-10-18 0000891417 NMGX:ConvertiblePromissoryNotesMember 2022-12-01 2022-12-18 0000891417 NMGX:ConvertiblePromissoryNotesMember 2022-12-18 0000891417 NMGX:ConvertiblePromissoryNotesMember 2023-06-14 2023-06-14 0000891417 NMGX:ConvertiblePromissoryNotesMember 2023-07-24 2023-07-24 0000891417 NMGX:ConvertiblePromissoryNotesMember 2023-07-24 0000891417 NMGX:ConvertiblePromissoryNotesMember 2023-11-02 2023-11-02 0000891417 NMGX:ConvertiblePromissoryNotesMember 2023-11-02 0000891417 NMGX:ConvertiblePromissoryNotesMember 2024-06-10 2024-06-10 0000891417 NMGX:ConvertiblePromissoryNotesMember 2024-06-10 0000891417 NMGX:ConvertiblePromissoryNotesMember 2024-06-30 0000891417 NMGX:ConvertiblePromissoryNotesMember 2023-12-31 0000891417 NMGX:ProductionEquipmentMember 2020-12-31 0000891417 NMGX:ProductionEquipmentMember 2020-12-01 2020-12-31 0000891417 2020-05-31 0000891417 2020-05-30 2020-05-31 0000891417 NMGX:LandLordAgreementMember 2023-02-01 2023-02-28 0000891417 NMGX:LandLordAgreementMember 2023-02-28 0000891417 NMGX:TomBermanAndRonBermanMember 2024-01-01 2024-06-30 0000891417 NMGX:MilesGatlandMember 2024-01-01 2024-06-30 0000891417 NMGX:LandLordAgreementMember 2023-05-31 0000891417 us-gaap:RestrictedStockMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestedInMayMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestAtEndOfMayMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestingAtEndOfDecemberThirtyOneTwoThousandTwentyThreeMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestAtEndOfEachMonthInDecemberThirtyOneTwoThousandTwentyFourMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestingAtEndOfDecemberThirtyOneTwoThousandTwentyFourMember 2023-05-29 2023-05-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2023-04-01 2023-06-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2023-06-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2023-01-01 2023-06-30 0000891417 us-gaap:WarrantMember 2024-06-30 0000891417 us-gaap:WarrantMember 2024-01-01 2024-06-30 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2023-04-12 2023-04-12 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2023-05-29 2023-05-30 0000891417 NMGX:TomJBermanMember 2023-04-12 2023-04-12 0000891417 NMGX:OfficersMember 2023-05-29 2023-05-30 0000891417 2023-01-01 2023-12-31 0000891417 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0000891417 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0000891417 us-gaap:WarrantMember 2024-01-01 2024-06-30 0000891417 us-gaap:WarrantMember 2023-01-01 2023-12-31 0000891417 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-06-30 0000891417 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-12-31 0000891417 us-gaap:SubsequentEventMember 2024-07-17 2024-07-18 0000891417 us-gaap:SubsequentEventMember 2024-07-29 0000891417 NMGX:AppliedNanotechIncMember us-gaap:SubsequentEventMember 2024-07-28 0000891417 NMGX:AppliedNanotechIncMember us-gaap:SubsequentEventMember 2024-07-29 0000891417 NMGX:TwoThousandTwentyOneEquityPlanMember us-gaap:SubsequentEventMember 2024-07-29 2024-07-29 0000891417 NMGX:TwoThousandTwentyOneEquityPlanMember us-gaap:SubsequentEventMember 2024-07-29 0000891417 NMGX:TomBermanMember us-gaap:SubsequentEventMember 2024-07-29 2024-07-29 0000891417 us-gaap:SubsequentEventMember NMGX:TomBermanMember NMGX:DecemberThirtyOneTwoThousandTwentyFourMember 2024-07-29 2024-07-29 0000891417 NMGX:TomBermanMember us-gaap:SubsequentEventMember 2024-07-29 0000891417 us-gaap:SubsequentEventMember NMGX:LeandroVeraMember 2024-07-29 2024-07-29 0000891417 NMGX:RonaldBermanMember us-gaap:SubsequentEventMember 2024-07-29 2024-07-29 0000891417 NMGX:ScottRickertMember us-gaap:SubsequentEventMember 2024-07-29 2024-07-29 0000891417 NMGX:JeanneRickertMember us-gaap:SubsequentEventMember 2024-07-29 2024-07-29 0000891417 us-gaap:SubsequentEventMember 2024-07-29 2024-07-29 0000891417 us-gaap:SubsequentEventMember 2024-08-05 2024-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares NMGX:Segment utr:sqft xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended June 30, 2024

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

COMMISSION FILE NO. 1-11602

 

NANO MAGIC INC.

(Exact name of registrant as specified in its charter)

 

Delaware   47-1598792
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

31601 Research Park Drive, Madison Heights, MI 48071

(Address of principal executive office, including Zip Code)

 

Registrant’s telephone number, including area code: (844) 273-6462

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol   Name of Each Exchange on Which Registered
Common Stock, $0.0001 par value   NMGX   OTC Markets

 

Securities registered pursuant to Section 12(g) of the Exchange Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “accelerated filer”, “large accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
   
Non-accelerated filer Smaller reporting company

 

Emerging growth company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes No.

 

As of August 19, 2024, the registrant had 14,008,675 shares of Common Stock issued and outstanding.

 

 

 

 

 

 

Nano Magic Inc.

 

INDEX

 

    Page
Part I. Financial Information    
     
Item 1. Financial Statements (Unaudited)   F-1
     
Condensed Statements of Operations—Three and Six Months Ended June 30, 2024 and 2023   F-1
     
Condensed Balance Sheets—June 30, 2024 and December 31, 2023   F-2
     
Condensed Statements of Changes in Stockholders’ (Deficit) Equity for the Three Months Ended June 30, 2024 and 2023   F-3
     
Condensed Statements of Changes in Stockholders’ (Deficit) Equity for the Six Months Ended June 30, 2024 and 2023   F-4
     
Condensed Statements of Cash Flows—Six Months Ended June 30, 2024 and 2023   F-5
     
Notes to Unaudited Condensed Financial Statements   F-6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   4
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk   7
     
Item 4. Controls and Procedures   7
     
Part II. Other Information    
     
Item 1. Legal Proceedings   8
     
Item 1A. Risk Factors   8
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   8
     
Item 3. Defaults Upon Senior Securities   8
     
Item 4. Mine Safety Disclosures   8
     
Item 5. Other Information   8
     
Item 6. Exhibits   9
     
Signatures   10

 

2

 

 

FORWARD-LOOKING STATEMENTS

 

This Form 10-Q contains certain forward-looking statements that we believe are within the meaning of the federal securities laws. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements, including the statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our strategy, future operations, future expectations or future estimates, financial position and objectives of management. Those statements in this Form 10-Q containing the words “believes,” “anticipates,” “plans,” “expects” and similar expressions constitute forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on our current expectations and are subject to a number of risks, uncertainties and assumptions relating to our operations, results of operations, competitive factors, shifts in market demand and other risks and uncertainties.

 

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate and actual results may differ from those indicated by the forward-looking statements included in this Form 10-Q. In light of the significant uncertainties inherent in the forward-looking statements included in this Form 10-Q, you should not consider the inclusion of such information as a representation by us or anyone else that we will achieve such results. Moreover, we assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements.

 

3

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NANO MAGIC INC.

CONDENSED STATEMENTS OF OPERATIONS

(unaudited)

 

   2024   2023   2024   2023 
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2024   2023   2024   2023 
                 
NET REVENUES  $616,623   $709,293   $1,196,735   $1,406,322 
                     
COST OF SALES   662,583    507,155    1,173,952    1,129,434 
                     
GROSS PROFIT   (45,960)   202,138    22,783    276,888 
                     
OTHER OPERATING INCOME   -    11,420    -    11,420 
                     
OPERATING EXPENSES:                    
Selling and marketing expenses   49,076    54,018    131,802    113,442 
Salaries, wages and related benefits   230,916    189,986    433,465    468,562 
Stock compensation expense   7,835    260,249    16,335    290,393 
Research and development   21,623    6,371    41,918    12,275 
Professional fees   176,331    112,762    394,450    302,221 
General and administrative expenses   256,291    258,508    527,719    447,514 
                     
Total Operating Expense   742,072    881,894    1,545,689    1,634,407 
                     
LOSS FROM OPERATIONS   (788,032)   (668,336)   (1,522,906)   (1,346,099)
                     
OTHER (EXPENSE) INCOME                    
Income from investment in subsidiary   -    8,782    10,123    40,938 
Loss from sale of note receivable   (26,782)   -    (41,782)   - 
Interest expense   (13,028)   (7,575)   (25,465)   (21,943)
Interest and other income   3,177    16,264    9,158    23,202 
Total Other (Expense) Income   (36,633)   17,471    (47,966)   42,197 
                     
NET LOSS   (824,665)   (650,865)   (1,570,872)   (1,303,902)
                     
NET LOSS PER COMMON SHARE                    
Basic  $(0.06)  $(0.06)  $(0.12)  $(0.12)
Diluted  $(0.06)  $(0.06)  $(0.12)  $(0.12)
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                    
Basic   13,565,122    10,963,268    13,502,764    10,907,579 
Diluted   13,565,122    10,963,268    13,502,764    10,907,579 

 

See accompanying notes to financial statements.

 

F-1

 

 

NANO MAGIC INC.

CONDENSED BALANCE SHEETS

(unaudited)

 

   2024   2023 
  June 30   December 31 
   2024   2023 
ASSETS          
           
CURRENT ASSETS:          
Cash  $71,869   $527,462 
Accounts receivable, net of allowance for credit losses of $248,919 and $150,300 at June 30, 2024 and December 31, 2023, respectively   100,425    209,057 
Inventory, net   751,158    849,764 
Prepaid expenses   17,957    63,538 
Current portion of note receivable   -    50,000 
Total Current Assets   941,409    1,699,821 
Operating lease right-of-use assets   727,814    845,563 
Property, plant and equipment, net   385,844    424,103 
Note receivable, non-current   -    291,782 
Non-marketable equity investment in subsidiary   263,959    253,835 
Total Assets  $2,319,026   $3,515,104 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
CURRENT LIABILITIES:          
Accounts payable  $634,663   $593,338 
Accounts payable - related parties   117,627    55,520 
Accrued expenses and other current liabilities   339,728    245,398 
Current portion of notes payable   400,000    121,610 
Current portion of notes payable from related party   25,000    - 
Current portion of finance leases   12,396    24,194 
Advances from related parties   42,887    42,887 
Current portion of operating lease liabilities   174,181    161,905 
Total Current Liabilities   1,746,482    1,244,852 
Notes Payable, net of current portion   148,378    375,000 
Notes Payable - related parties, net of current portion   -    25,000 
Operating lease liabilities, net of current portion   456,465    560,514 
Total Liabilities   2,351,325    2,205,366 
           
Commitments and Contingencies (See Note 8)   -     -  
           
STOCKHOLDERS’ (DEFICIT) EQUITY:          
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding   -    - 
Common stock: $0.0001 par value, 30,000,000 shares authorized; 13,708,676 and 13,425,342 issued and outstanding at June 30, 2024 and December 31, 2023, respectively   1,371    1,342 
Additional paid-in capital   16,539,674    16,310,868 
Accumulated deficit   (16,573,344)   (15,002,472)
Total Stockholders’ (Deficit) Equity   (32,299)   1,309,738 
Total Liabilities and Stockholders’ Equity  $2,319,026   $3,515,104 

 

See accompanying notes to financial statements.

 

F-2

 

 

NANO MAGIC INC.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

FOR THE THREE MONTHS ENDED JUNE 30, 2024 AND 2023

(unaudited)

 

                          
                   Total 
   Class A Common Stock   Additional
Paid-in
   Accumulated   Stockholders’
(Deficit)
 
   Shares   Amount   Capital   Deficit   Equity 
                          
Balance, March 31, 2024   13,498,676   $1,349   $16,374,361   $(15,748,679)   627,031 
                          
Common stock issued for cash, net of issuance costs   210,000    22    157,478    -    157,500 
                          
Restricted stock issued for services   -    -    5,691    -    5,691 
                          
Stock-based compensation   -    -    2,144    -    2,144 
                          
Net loss   -    -    -    (824,665)   (824,665)
                          
Balance, June 30, 2024   13,708,676    1,371    16,539,674    (16,573,344)   (32,299)
                     
Balance, March 31, 2023   10,850,037   $1,084   $13,954,274   $(12,799,790)   1,155,568 
                          
Common stock issued for cash, net of issuance costs   253,994    25    346,039    -    346,064 
                          
Stock-based compensation   -    -    255,539    -    255,539 
                          
Stock issued for services   76,922    8    4,702    -    4,710 
                          
Warrants and options on private placement   -    -    9,269    -    9,269 
                          
Net loss   -    -    -    (650,865)   (650,865)
                          
Balance, June 30, 2023   11,180,953    1,117    14,569,823    (13,450,655)   1,120,285 

 

See accompanying notes to condensed financial statements.

 

F-3

 

 

NANO MAGIC INC.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023

(unaudited)

 

                          
                   Total 
   Class A Common Stock   Additional
Paid-in
   Accumulated   Stockholders’
(Deficit)
 
   Shares   Amount   Capital   Deficit   Equity 
                          
Balance, December 31, 2023   13,425,342   $1,342   $16,310,868   $(15,002,472)   1,309,738 
                          
Common stock issued for cash, net of issuance costs   283,334    29    212,471    -    212,500 
                          
Restricted stock issued for services   -    -    11,382    -    11,382 
                          
Stock-based compensation   -    -    4,953    -    4,953 
                          
Net loss   -    -    -    (1,570,872)   (1,570,872)
                          
Balance, June 30, 2024   13,708,676    1,371    16,539,674    (16,573,344)   (32,299)
                     
Balance, December 31, 2022   10,722,431   $1,072   $13,763,143   $(12,146,753)   1,617,462 
                          
Common stock issued for cash, net of issuance costs   328,800    32    439,539    -    439,571 
                          
Stock-based compensation   -    -    285,683    -    285,683 
                          
Stock issued for services   52,800    5    65,995    -    66,000 
                          
Restricted stock issued for services   76,922    8    4,702    -    4,710 
                          
Warrants and options on private placement   -    -    10,761    -    10,761 
                          
Net loss   -    -    -    (1,303,902)   (1,303,902)
                          
Balance, June 30, 2023   11,180,953    1,117    14,569,823    (13,450,655)   1,120,285 

 

See accompanying notes to condensed financial statements.

 

F-4

 

 

NANO MAGIC INC.

CONDENSED STATEMENTS OF CASH FLOWS

(unaudited)

 

   2024   2023 
   For the Six Months Ended 
   June 30, 
   2024   2023 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss  $(1,570,872)  $(1,303,902)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Change in inventory obsolescence reserve   80,279    (3,680)
Depreciation and amortization expense   53,817    56,265 
Bad debt expense   98,619    47,997 
Stock issued for services   11,382     70,710 
Stock-based compensation   4,953    285,683 
Income from investment in subsidiary   (10,123)   (40,938)
Change in operating assets and liabilities:          
Accounts receivable   10,014    (53,181)
Inventory   18,327    74,190 
Prepaid expenses and contract assets   45,581    109,794 
Accounts payable   83,104    (47,650)
Accounts payable - related party   62,107    13,498 
Operating lease liabilities   25,977    14,190 
Accrued expenses   94,330    51,629 
Total adjustments   578,367    578,507 
         - 
NET CASH USED BY OPERATING ACTIVITIES   (992,505)   (725,395)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Proceeds from note receivable   300,000    20,000 
Purchases of property and equipment   (15,558)   (2,829)
           
NET CASH PROVIDED BY INVESTING ACTIVITIES   284,442    17,171 
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from sale of common stock and warrants   212,500    445,000 
Proceeds from issuance of convertible debt and warrants   50,000    50,000 
Repayment of bank loans   -    (1,630)
Repayment of finance leases   (10,030)   (24,556)
           
NET CASH PROVIDED BY FINANCING ACTIVITIES   252,470    468,814 
           
NET DECREASE IN CASH   (455,593)   (239,410)
           
CASH, beginning of period   527,462    259,223 
           
CASH, end of period  $71,869   $19,813 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid during the period for interest  $1,012   $21,943 

 

See accompanying notes to condensed financial statements.

 

F-5

 

 

NANO MAGIC INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2024

(unaudited)

 

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

 

Organization

 

Nano Magic Inc. (“we”, “us”, “our”, “Nano Magic” or the “Company”), a Delaware corporation, develops and sells a portfolio of nano-layer coatings, nano-based cleaners, and nano-composite products based on its proprietary technology.

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information. Accordingly, they do not include all the information and disclosures required by US GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed financial statements of the Company as of June 30, 2024 and for the three and six months ended June 30, 2024 and 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the operating results for the full year ending December 31, 2024 or any other period. The balance sheet at December 31, 2023 has been derived from the audited financial statement at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and related disclosures of the Company as of December 31, 2023 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 3, 2024.

 

Going Concern

 

These unaudited financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the unaudited financial statements, the Company had losses from operations and net cash used by operations of $1,522,906 and $992,505 for the six months ended June 30, 2024 and a loss from operations of $1,346,099 and net cash used by operations of $725,395 for the six months ended June 30, 2023. Moreover, at June 30, 2024, the Company had a working capital deficit of $(805,072) as compared to positive working capital of $454,969 at December 31, 2023. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited financial statements are issued. Management cannot provide assurance that the Company will ultimately achieve profitable operations, become cash flow positive or raise additional capital. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. They do not include any adjustments related to the recoverability and/or classification of the recorded asset amounts and/or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Reclassifications

 

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period. These reclassifications had no effect on the previously reported net loss.

 

NOTE 2 – INVENTORY

 

At June 30, 2024 and December 31, 2023, inventory consisted of the following:

 

   June 30, 2024   December 31, 2023 
Raw materials  $677,239   $648,537 
Work-in-progress   219,856    235,811 
Finished goods   265,847    296,921 
Inventory, gross   1,162,942    1,181,269 
Less: reserve for obsolescence   (411,784)   (331,505)
Inventory, net  $751,158   $849,764 

 

F-6

 

 

NOTE 3 – INVESTMENT IN SUBSIDIARY

 

For the three- and six-month periods ended June 30, 2024, we sold portions of the note receivable from ANI to various parties for total cash proceeds of $100,000 and $300,000, respectively, incurring a loss on the sale of the note of $15,000 and $41,782, respectively. The losses were recorded in Other Expense in the statement of operations. As a result, at June 30, 2024, the note receivable had a balance of $0 as compared to $341,782 at December 31, 2023; $0 was included in current assets at June 30, 2024 with $50,000 included in current assets at December 31, 2023.

 

The Company is accounting for its 30% ownership interest in ANI by the equity method of accounting under which the Company’s share of the net income (loss) of ANI is recognized as income (loss) in the Company’s statement of operations. Any dividends received from ANI as well as periodic losses for the Company’s 30% share will be treated as a reduction of the investment account. Periodic income will be treated as an increase in the investment account. At June 30, 2024 and December 31, 2023, the non-marketable investment in subsidiary was $263,959 and $253,835, included in non-current assets. For the three- and six-month periods ended June 30, 2024, the Company recorded income from the investment in the subsidiary of $0 and $10,123 respectively. For the three and six-month periods ended June 30, 2023, the Company recorded income of $8,782 and $40,938, respectively. See Note 9, Subsequent Events, describing the sale of a part of our interest in ANI.

 

NOTE 4 – NOTES PAYABLE AND FINANCE LEASE

 

Notes Payable

 

On January 7, 2022, the Company sold to one investor a $100,000 convertible note due March 31, 2025. On January 26, 2022, and January 31, 2022, the Company sold two $50,000 convertible notes to two different investors. The $50,000 notes are due March 31, 2025 and March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On July 27, 2022, the Company sold two convertible notes, one for $50,000 and one for $25,000, both due on March 31, 2025. The $25,000 note is to Mr. Ron Berman, a Related Party. On August 22, 2022, the Company sold a $25,000 convertible promissory note due March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On October 26, 2022, the Company sold to an investor a $25,000 convertible promissory note due October 31, 2023. Issued at face value, the note bears interest at 8% per annum, payable semi-annually in cash. The note is convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share. On October 18, 2023, the Company and the holder extended the maturity date of the note to October 31, 2024.

 

On December 18, 2022, the Company issued a convertible promissory note for $50,000 that is secured by certain payroll tax credits the Company is entitled to receive under the Employee Retention Tax Credit program. The note was issued at face value and bears interest at 8% per annum, payable at maturity on June 18, 2024. The note can be converted to common stock at any time at the option of the holders at a conversion price of $1.75 per share at which point accrued interest will be paid in cash. At June 30, 2024, the note remains unpaid.

 

On June 14, 2023, the Company issued a convertible, secured note and warrants to purchase 10,000 shares of the Company’s common stock for $50,000 with the same terms as the one issued on December 18, 2022. The warrants were recorded as a debt discount on the date of issuances for a total value of $5,333. The balance at June 30, 2024 and December 31, 2023 of the debt discount was $1,622 and $3,390, respectively.

 

On July 24, 2023, the Company issued at face value a convertible note in the original principal amount of $50,000. The note is due on July 24, 2025, bears interest at 8% per annum and is convertible at $1.25 per share.

 

On November 2, 2023, the Company issued at face value a convertible note in the original principal amount of $50,000. The note is due on November 2, 2025, bears interest at 8% per annum and is convertible at $1.25 per share.

 

On June 10, 2024, the Company issued a $50,000 promissory note to an investor. The note bears interest at 1% per month and all principal and interest is payable 120 days from the date of issuance. The note is secured by two purchase orders from a large customer.

 

At June 30, 2024 and at December 31, 2023, we had outstanding convertible notes aggregating $575,000 and $525,000 in principal amount. The convertible promissory notes have not been included in diluted earnings per share as they would be anti-dilutive.

 

F-7

 

 

Finance Lease

 

In December 2020, the company entered into a finance lease for production equipment. We financed $85,000 over a period of 48 months with monthly payments of $2,135 during that time. At June 30, 2024 and December 31, 2024, the balances on the finance lease were $12,396 and $24,194, respectively. These balances are included in current liabilities on the balance sheet.

 

NOTE 5 – OPERATING LEASE

 

Effective May 31, 2020, we entered into a lease with a related party for a 29,220 square foot building in Madison Heights, Michigan. The occupancy and rent commencement date was October 1, 2020. The lease has an initial term of seven years with a renewal option at the end of the initial term for an additional 3-year term, and a second renewal option thereafter for an additional 5-year term. The renewal term is not included in the calculation of the operating lease liability. As the sole tenant, we are responsible for all taxes, ordinary maintenance, snow removal and other ordinary operating expenses. Rent is $6.50 per square foot, increasing by $0.25 per year. During the first three years we had the right to buy up to a 49% interest in Magic Research LLC for a price equal to 49% of the contributions received from other members. This right has now expired as we did not exercise the option. See Note 7, Stockholders’ Equity, for a description of warrants issued to the owners of Magic Research LLC in connection with this lease. The fair value of these warrants totaling $311,718 were recorded as initial direct costs of obtaining the lease and are included in right-of-use assets on the accompanying balance sheet. See Note 6, Related Party Transactions, for information about roles in management and economic participation by our CEO and several other directors in the landlord.

 

In February 2023, we reached an agreement with the landlord of our Michigan facility to accept $66,000 worth of our common stock at a price of $1.25 per share as partial payment of rent for the six-month period from October 2022 through March 2023. During that period, we paid cash of $8,056 per month, effectively a cash rent reduction of $10,983 per month. In May 2023, we reached a further agreement with the landlord under which we pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $0.75 per share. We have the option to continue to use stock to pay a portion of the rent through 2024.

 

For operating leases, we calculated ROU assets and lease liabilities based on the present value of the remaining lease payments as of the date of adoption using the IBR as of that date. The ROU Asset was $727,814 at June 30, 2024 and $845,563 at December 31, 2023. The operating lease liability was $630,646 at June 30, 2024 and $722,419 at December 31, 2023.

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

At June 30, 2024 and at December 31, 2023, accounts payable – related parties totaled $117,627 and $55,520, respectively, and advances from related parties totaled $42,887 on both dates. These balances are presented separately in current liabilities on the accompanying balance sheets. These balances consist of amounts owed to directors and officers as well as to the landlord controlled by two of the Company’s directors.

 

F-8

 

 

See Note 9, Subsequent Events, regarding options granted to, among others, officers and certain directors.

 

Mr. Ron Berman and Mr. Tom Berman are the managers of the limited liability company that is the manager of PEN Comeback, LLC, PEN Comeback 2, LLC, Magic Growth, LLP, Magic Growth 2 LLC and Magic Growth 3 LLC. These five limited liability companies purchased shares of common stock and derivative securities from us in 2018, 2019, 2020, 2021 and 2022.

 

In addition, Mr. Tom Berman and Mr. Ron Berman are two of three individuals who share voting power of the sole manager of the limited liability company that is our landlord in Michigan. Together, Tom and Ron Berman hold, in the aggregate, a 5% economic interest in the landlord entity. Another director, Miles Gatland, owns a 12.5% interest in the Michigan landlord and he is a co-guarantor on the debt of that limited liability company. See Note 7, Stockholder’s Equity regarding the issuance of stock in partial satisfaction of unpaid rent. At June 30, 2024 and at December 31, 2023, rents accrued and unpaid totaled $93,627 and $30,141, respectively, which are included in related parties accounts payable on the balance sheet.

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Description of Preferred and Common Stock

 

Preferred Stock

 

The preferred stock may be issued in one or more series. The Company’s board of directors are authorized to issue the shares of preferred stock in such series and to fix from time to time before issuance thereof the number of shares to be included in any such series and the designation, powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, of such series.

 

Common Stock

 

The rights of each share of common are the same with respect to dividends, distributions and rights upon liquidation. Holders of common stock each have one vote per share in the election of directors and other matters submitted to a vote of the stockholders.

 

Issuances of Common Stock

 

Common Stock Issued for Services

 

In February 2023, we reached an agreement with the landlord of our Michigan facility to accept 52,800 shares of our common stock at a price of $1.25 per share as partial payment of rent for the six-month period from October 2022 through March 2023. Those shares were issued in March, 2023. In May 2023, we reached a further agreement with the landlord that calls for us to pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $0.75 per share. We have the option to continue to use stock to pay a portion of the rent through 2024. The landlord is a Related Party.

 

On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services. The shares are subject to forfeiture until vested. So long as the consulting services agreement remains in effect 4,273 shares vested in May for prior service, and another 4,273 shares vest at the end of May and each calendar month thereafter, with 4,277 shares vesting in December 2023. During 2024, 3,205 shares will vest at the end of each month, with 3,206 shares vesting at the end of December 2024.

 

Sales of Common Stock and Derivative Equity Securities

 

During the quarter ended June 30, 2024, the Company sold 210,000 shares of common stock for proceeds of $157,500. During the six-months ended June 30, 2024, the Company sold 283,334 shares of common stock for proceeds of $212,500.

 

F-9

 

 

During the quarter ended June 30, 2023, the Company sold 253,994 shares of common stock for proceeds of $346,064 and warrants to purchase up to 196,813 shares of common stock for proceeds of $4,136. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. During the six-months ended June 30, 2023, the Company sold 328,800 shares of common stock for proceeds of $439,571 and warrants to purchase up to 271,439 shares of common stock for proceeds of $5,428. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. Also, during the three-months ended June 30, 2023, the Company sold 10,000 warrants in connection with the issuance of a convertible note payable of $50,000 as disclosed in Note 5. In accordance with ASC 470, 11% of the value of the total convertible note payable was allocated to the warrants.

 

Stock Options

 

Stock options to purchase common stock outstanding at June 30, 2024 include those described below. No options were exercised during the period. No options have been included in diluted earnings per share as they would be anti-dilutive.

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
  

Aggregate

Intrinsic

Value

 
Outstanding December 31, 2023   2,270,483   $0.67    2.72   $76,725 
Exercised   -    -    -    - 
Issued   -    -    -    - 
Expired & forfeited   (55,297)  $0.65    -    - 
Outstanding June 30, 2024   2,215,186   $0.67    3.41   $348,088 
                     
Exercisable June 30, 2024   2,201,545   $0.67    3.41   $346,276 

 

   June 30, 2024   December 31, 2023 
Stock options   2,215,186    2,270,483 
Stock warrants   7,525,265    7,525,265 

Convertible debt (on an as-converted basis)

   

362,738

    

349,824

 
Total   10,103,189    10,145,572 

 

Warrants

 

As of June 30, 2024, there were outstanding and exercisable warrants to purchase 7,525,265 shares of common stock. The outstanding warrants have a weighted average exercise price of $1.72 per share and a weighted average remaining contractual term of 34.7 months. As of June 30, 2024 and December 31, 2023, there was no intrinsic value for the warrants. No warrants have been included in diluted earnings per share as they would be anti-dilutive.

 

2021 Equity Incentive Plan

 

On March 2, 2021, our Board adopted the 2021 Nano Magic 2021 Equity Incentive Plan (the “Plan”) to allow equity compensation for those who provide services to the Company and to encourage ownership in the Company by personnel whose service to the Company is important to its continued progress, to encourage recipients to act as owners and thereby in the stockholders’ interest and to enable recipients to share in the Company’s success.

 

On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan. On May 30, 2023 the Board granted an additional 175,071 options under the 2021 Equity Plan to employees and a consultant. All options are at an exercise price of $0.65.

 

See Note 9, Subsequent Events, regarding additional options granted under the 2021 Equity Plan.

 

F-10

 

 

Other Options

 

On April 12, 2023, the Company issued an additional 30,000 options to Tom J. Berman, our President. On May 30, 2023, the Board granted 384,228 options to officers and to a consultant who is also a director.

 

See Note 9, Subsequent Events, regarding options granted to officers and certain directors.

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may be, from time to time, subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. As of June 30, 2024 we were not a defendant in any proceedings. Our policy is to accrue costs for contingent liabilities, including legal proceedings or unasserted claims that may result in legal proceedings, when a liability is probable and the amount can be reasonably estimated. As of June 30, 2024 and December 31, 2023, the Company has not accrued any amount for litigation contingencies.

 

NOTE 9 – SUBSEQUENT EVENTS

 

On July 18, 2024, the Company sold an aggregate of 166,666 shares of common stock for proceeds of $125,000 to two different investors.

 

On July 29,2024, the Board authorized the sale of a portion of the Company’s interest in Applied Nanotech, Inc. The sale was consummated on the same day; the Company received $100,000 in cash and its interest in Applied Nanotech was reduced from 30% to 25%.

 

On July 29, 2024, The Company granted 411,268 options to employees, contractors and consultants under the 2021 Equity Plan and increased amounts available for grant by that number. All options entitle the holder to purchase shares at a strike price of $0.31 and expire five years from date of grant.

 

On July 29, 2024, the Company also granted options to our President & CEO, Tom Berman: 250,000 vesting on date of grant, 250,000 vesting on December 31,2024, and 1,000,000 that will vest if he earns a Profit Bonus under his contract and the Board elects to pay some or all of that bonus with options. On that same day, the Board granted 60,000 options to our Chief Financial Officer, Leandro Vera, 60,000 options to director Ronald Berman, 30,000 options to director Scott Rickert and 30,000 options to director and Secretary Jeanne Rickert. These options were 50% vested on date of grant and will vest ratably over the remainder of 2024. Options to officers and directors were not issued under the Plan, but these options also entitle the holder to purchase shares at a strike price of $0.31 and expire five years from date of grant.

 

On August 5, 2024, the Company sold 133,333 shares for proceeds of $100,000.

 

F-11

 

 

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying unaudited condensed financial statements.

 

OVERVIEW

 

Nano Magic develops, commercializes and markets nanotechnology powered consumer and industrial cleaners and coatings to clean, protect, and enhance products for peak performance. Consumer products include lens and screen cleaners and coatings, anti-fog solutions, and household and automobile cleaners and protective coatings sold direct-to-consumer and in big box retail. Nano Magic also sells branded and private label cleaners and coatings into the optical, safety, and industrial channels. Our focus is to expand our direct-to-consumer sales through e-commerce and to grow sales to big box retailers. We continue to sell our consumer products directly to opticians and ophthalmologists and small optical retailers.. Visit www.nanomagic.com for more information.

 

RESULTS OF OPERATIONS

 

The following comparative analysis on results of operations was based primarily on the comparative condensed financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the unaudited condensed financial statements and the notes to those statements that are included elsewhere in this report. The results discussed below are for the three and six months ended June 30, 2024 and 2023.

 

Comparison of Results of Operations for the Three and Six Months ended June 30, 2024 and 2023

 

Revenues:

 

For the three and six months ended June 30, 2024 and 2023, revenues from operations were:

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2024   2023   2024   2023 
Net revenues  $616,623   $709,293   $1,196,735   $1,406,322 

 

For the three months ended June 30, 2024, revenues from operations decreased by $92,670 or 13% as compared to the three months ended June 30, 2023. For the six months ended June 30, 2024 revenues decreased by $209,587 or 15%, as compared to the six months ended June 30, 2023. The decreases were due to a slowdown in purchasing from key customers and changes in product mix.

 

Cost of sales

 

Cost of sales includes inventory costs, materials and supplies costs, internal labor and related benefits, subcontractor costs, depreciation, periodic changes in the inventory reserve, and allocated overheads and shipping and handling costs incurred.

 

   Three Months ended June 30,   Six Months ended June 30, 
   2024   2023   2024   2023 
Cost of sales:  $662,583   $507,155   $1,173,952   $1,129,434 

 

For the three months ended June 30, 2024, cost of revenues increased by $155,428 or 31% as compared to the three months ended June 30, 2023. For the six months ended June 30, 2024, cost of revenues increased by $44,518 or 4% as compared to the six months ended June 30, 2023. Cost of sales increased as sales revenue decreased due to a significant increase in the reserve for slow-moving and excess inventory in 2024 as compared to 2023. Management is currently focusing efforts on reducing this inventory by way of new programs and incentives with customers.

 

4

 

 

Gross profit

 

For the three months ended June 30, 2024, gross profit was $(45,960) as compared to gross profit of $202,138 for the prior year, a decrease of $248,098 or 123%. For the six months ended June 30, 2024, gross profit was $22,783 as compared to $276,888 for the prior year, a decrease of $254,105 or 92%. For the three- and six-month periods the decreases were due to lower sales volumes and higher inventory reserves year over year.

 

Operating expenses

 

For the three months ended June 30, 2024, operating expenses decreased by $139,822 or 16% compared to the three months ended June 30, 2023. For the six-month period ended June 20, 2024, operating expenses decreased by $88,718 or 5% as compared to the six months ended June 30, 2023. For the three and six months ended June 30, 2024 and 2023, operating expenses consisted of the following:

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2024   2023   2024   2023 
Selling and marketing expenses  $49,076   $54,018   $131,802   $113,442 
Salaries, wages and related benefits   230,916    189,896    433,465    468,562 
Stock compensation expense   7,835    260,249    16,335    290,393 
Research and development   21,623    6,371    41,918    12,275 
Professional fees   176,331    112,762    394,450    302,221 
General and administrative expenses   256,291    258,508    527,719    447,514 
Total  $742,072   $881,894   $1,545,689   $1,634,407 

 

For the three months ended June 30, 2024, selling and marketing expenses decreased by $4,942 or 9% as compared to the three months ended June 30, 2023. For the six months ended June 30, 2024, selling and marketing expenses increased by $18,360 or 16% as compared to the six months ended June 30, 2023. The year-to-date change in 2024 as compared to 2023 is driven by an increase in promotional and trade show expenses, while the quarter-to-date change in 2024 as compared to 2023 is mostly timing related.
   
For the three months ended June 30, 2024, salaries, wages and related benefits increased by $40,930 or 22%, as compared to the three months ended June 30, 2023. For the six months ended June 30, 2024, salaries, wages and related benefits decreased by $35,097 or 7%, as compared to the six-months ended June 30, 2023. On a year-over-year basis, the year-to-date change reflects a decrease in costs related to medical benefits, while the quarter-to-date change is mostly related to increased commissions and timing of costs incurred.
   
For the three months ended June 30, 2024, stock compensation expense decreased by $252,414 or 97%. For the six months ended June 30, 2024, stock compensation expense decreased $274,058 or 94%. The decrease was primarily due to the lack of any option grants in the three- and six-month periods in 2024.

 

For the three months ended June 30, 2024, research and development costs increased by $15,252 or 239%, as compared to the three months ended June 30, 2023. For the six months ended June 30, 2024, research and development costs increased by $29,643 or 241%, as compared to the six months ended June 30, 2023. The increases were primarily due to the use of outside consultants for new product development in 2024.
   
For the three months ended June 30, 2024, professional fees increased by $63,569 or 56%, as compared to the three months ended June 30, 2023. For the six months ended June 30, 2024, professional fees increased by $92,229 or 31%, as compared to the six months ended June 30, 2023. The changes were primarily due to increased audit fees and reliance on outside consultants for business development, offset by a decrease in legal fees overall for the company.
   
For the three months ended June 30, 2024, general and administrative expenses decreased by $2,217 or 1% as compared to the three months ended June 30, 2023, essentially flat. For the six months ended June 30, 2024, general and administrative expenses increased by $80,205 or 18% as compared to the six months ended June 30, 2023. The year-over-year change in the six month period was primarily driven by an increased allowance for credit losses as well as increased travel expenses.

 

5

 

 

Loss from operations

 

As a result of the factors described above, for the three months ended June 30, 2024, loss from operations amounted to $788,032 as compared to a loss of $668,336 for the three months ended June 30, 2023, an increase of $119,696 or 18%. For the six months ended June 30, 2024, loss from operations amounted to $1,522,906 as compared to a loss of $1,346,099 for the six months ended June 30, 2023, an increase of $176,807 or 13%.

 

Income from investment in subsidiary

 

As a result of the sale of a 70% interest in ANI , we now report our 30% share of ANI’s income or loss as an investment in a subsidiary. For the three and six months ended June 30, 2024 there was income of $0 and $10,123, respectively. For the three and six-month periods ended June 30, 2023, we recorded income of $8,782 and $40,938, respectively.

 

Loss from sale of note receivable

 

In 2024 we sold our note receivable from ANI, realizing cash, but recording a loss. For the three- and six-month periods ending June 30, 2024, the loss was $26,782, and $41,782.

 

Interest expense

 

For the three months ended June 30, 2024 interest expense was $13,028 as compared to $7,575 in the prior year, and for the six months ended June 30, 2024 interest expense was $25,465 as compared to $21,943 in the prior year. In 2024, the increases were due to higher interest charges associated with the company’s issuance of convertible promissory notes.

 

Interest and other income

 

For the three months ended June 30, 2024 interest and other income was $3,178 as compared to $16,264 in the prior year, and for the six months ended June 30, 2024 interest and other income was $9,158 as compared to $23,202 in the prior year. In 2024, the decreases were due to a decreased balance on the ANI note receivable resulting in lower interest income for the Company.

 

Other (expense) income

 

For the three and six months ended June 30, 2024, other expense amounted to $(36,632), and $(47,966), respectively, as compared to other income of $17,471 and $42,197 for the three and six months ended June 30, 2023. The changes were due to the above factors.

 

Net loss

 

As a result of the foregoing, we reported a net loss of $824,665 for the three-month period ended June 30, 2024 and a net loss of $650,865 for the three-month period in the prior year, an increase of $173,800 or 27%. For the six-month period ended June 30, 2024 our net loss was $1,570,872 as compared to $1,303,902 for the six-month period ended June 30, 2023, an increase of $266,970 or 20%.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had working capital of $(805,072) and $71,869 of unrestricted cash as of June 30, 2024 and working capital of $454,969, including $527,462 of cash as of December 31, 2023.

 

The following table sets forth a summary of changes in our working capital from December 31, 2023 to June 30, 2024:

 

          

December 31, 2023 to

June 30, 2024

 
   June 30,
2024
   December 31, 2023  

Change in

Working

Capital

  

Percentage

Change

 
Working capital:                    
Total current assets  $941,409   $1,699,821   $(758,412)   (44.62)%
Total current liabilities   1,746,482    1,244,852    501,630    40.30%
Working capital:  $(805,072)  $454,969   $(1,260,041)   (276.95)%

 

6

 

 

The decrease in current assets was a combination of a reduction in cash, net inventory and prepaid expenses, as well as the sale of the note receivable. The increase in current liabilities was a combination of an increase in accounts payable, accrued expenses, and the current portion of notes payable. The current portion of notes payable includes a note in the principal amount of $50,000 that is past its maturity date.

 

Net cash used by operating activities was $(992,505) for the six months ended June 30, 2024 as compared to net cash used by operating activities of $(725,395) for the six months ended June 30, 2023, a net change of $(267,110) or 37%. Net cash used by operating activities for the six months ended June 30, 2024 primarily resulted from a net loss of $1,570,872 adjusted for add-backs of $238,927 and changes in operating assets and liabilities of $339,440.

 

Net cash provided by investing activities was $284,442 for the six months ended June 30, 2024, as compared to net cash provided by investing activities of $17,171 for the same period in 2023. The change was primarily due to the sale of the note receivable.

 

Net cash provided by financing activities was $252,470 for the six months ended June 30, 2024 reflecting $262,500 in proceeds from sales of common stock and convertible debt, as compared to net cash provided by financing activities of $468,814 for the same period in 2023. The reduction in 2024 was primarily due to a decrease in proceeds from the sale of common stock and convertible debt.

 

Future Liquidity and Capital Needs.

 

Our principal future uses of cash are for working capital requirements, including working capital to support increased product sales, sales and marketing expenses and reduction of accounts payable and accrued liabilities. Application of funds among these uses will depend on numerous factors including our sales and other revenues and our ability to control costs.

 

Equipment Financing and Loans

 

See notes 4 and 5 to our unaudited condensed financial statements regarding our equipment loan and financing leases.

 

Off-Balance Sheet Arrangements

 

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as shareholder’s equity or that are not reflected in our unaudited financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

 

ITEM 3. Quantitative and Qualitative disclosures about market risk

 

Not applicable to smaller reporting companies.

 

ITEM 4. Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report (the “Evaluation Date”). This evaluation included consideration of past practices, new resources, and implementation of a new payables system recently adopted in 2024. Based upon this evaluation, we do not believe we have a material weakness in the Company’s internal controls and procedures.

 

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

Changes in Internal Control

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

7

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None

 

ITEM 1A. RISK FACTORS

 

Not required of smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On April 17, 2024, the Company sold 33,333 shares of common stock for proceeds of $25,000. On April 24, 2024, the Company sold 33,333 shares of common stock to another investor for proceeds of $25,000.

 

On June 12, 2024, the Company sold 36,667 shares of common stock for proceeds of $27,500. On June 13, 2024, the Company sold 26,667 shares for $20,000. On June 25, 2024, the Company sold 13,333 shares for $10,000. On June 27, 2024, the Company sold 66,667 shares for $50,000.

 

On July 18, 2024, the Company sold an aggregate of 166,666 shares of common stock for proceeds of $125,000.

 

On July 29, 2024, The Company granted 411,268 options to employees, contractors and consultants under the 2021 Equity Plan and increased amounts available for grant by that number. A total of 37,288 of those options were 25% vested on date of grant, and will vest ratably over the rest of 2024 and all of 2025. A total of 322,000 of the options granted under the 2021 Equity Plan were vested 50% on date of grant and will vest ratably over the remainder of 2024. The remaining 51,980 options were fully vested on date of grant. All options entitle the holder to purchase 1 share per option at a strike price of $.031 and expire five years from date of grant.

 

On July 29, 2024, the Company also granted options to our President & CEO, Tom Berman: 250,000 vesting on date of grant, 250,000 vesting on December 31,2024, and 1,000,000 that will vest if he earns a Profit Bonus under his contract and the Board elects to pay some or all of that bonus with options. On that same day the Board granted 60,000 options to our Chief Financial Officer, Leandro Vera, 60,000 options to director Ronald Berman, 30,000 options to director Scott Rickert and 30,000 options to director and Secretary Jeanne Rickert. These options were 50% vested on date of grant and will vest ratably over the remainder of 2024. Options to officers and directors were not issued under the Plan, but these options also entitle the holder to purchase 1 share per option at a strike price of $.031 and expire five years from date of grant.

 

On August 5, 2024, the Company sold 133,333 shares for proceeds of $100,000.

 

Grants under the 2021 Equity Plan were exempt under Rule 701. The sales and issuances of stock and other securities were exempt from registration under Section 4(a)(2) of the Securities Act. Cash proceeds were used for general corporate purposes.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

8

 

 

ITEM 6. EXHIBITS

 

Exhibit
No.
  Description
31.1*   Rule 13a-14(a)/15d-14(a) Certificate of Principal Executive Officer
     
31.2*   Rule 13a-14(a)/15d-14(a) Certificate of Chief Financial Officer
     
32.1*   Section 1350 Certificate of Principal Executive Officer and Chief Financial Officer
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema
     
101.CAL   Inline XBRL Taxonomy Extension Calculation
     
101.DEF   Inline XBRL Taxonomy Extension Definition
     
101.LAB   Inline XBRL Taxonomy Extension Labels
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
*   Filed herewith.

 

9

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Nano Magic Inc.

(Registrant)

   
Date: August 19, 2024 /s/ Tom J. Berman
  Tom J. Berman,
  President and Chief Executive Officer
   
Date: August 19, 2024 /s/ Leandro Vera
  Leandro Vera
  Chief Financial Officer

 

10

 

Exhibit 31.1

 

Certificate of Principal Executive Officer

Pursuant to Rule 13a-14(a)/15d-14(a)

 

I, Tom J. Berman, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended June 30, 2024 of Nano Magic Inc. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present, in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting) as defined in the Exchange Act Rules 13a - 15(f) and 15d - 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 19, 2024 /s/ Tom J. Berman
 

Tom J. Berman

President and Chief Executive Officer

 

 

 

Exhibit 31.2

 

Certificate of Principal Financial Officer

Pursuant to Rule 13a-14(a)/15d-14(a)

 

I, Leandro Vera, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended June 30, 2024 of Nano Magic Inc. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present, in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting) as defined in the Exchange Act Rules 13a - 15(f) and 15d - 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 19, 2024 /s/ Leandro Vera
  Leandro Vera
  Chief Financial Officer

 

 

 

Exhibit 32.1

 

Section 1350 Certification of Principal Executive Officer

 

In connection with the quarterly report of Nano Magic Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tom J. Berman, President of the Company, and I, Leandro Vera, Chief Financial Officer, certify to the best of our knowledge:

 

1. The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 19, 2024 /s/ Tom J. Berman
  Tom J. Berman
  President and Chief Executive Officer
   
Date: August 19, 2024 /s/ Leandro Vera
  Leandro Vera
  Chief Financial Officer

 

 
v3.24.2.u1
Cover - shares
6 Months Ended
Jun. 30, 2024
Aug. 19, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 1-11602  
Entity Registrant Name NANO MAGIC INC.  
Entity Central Index Key 0000891417  
Entity Tax Identification Number 47-1598792  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 31601 Research Park Drive  
Entity Address, City or Town Madison Heights  
Entity Address, State or Province MI  
Entity Address, Postal Zip Code 48071  
City Area Code (844)  
Local Phone Number 273-6462  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol NMGX  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   14,008,675
v3.24.2.u1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
NET REVENUES $ 616,623 $ 709,293 $ 1,196,735 $ 1,406,322
COST OF SALES 662,583 507,155 1,173,952 1,129,434
GROSS PROFIT (45,960) 202,138 22,783 276,888
OTHER OPERATING INCOME 11,420 11,420
OPERATING EXPENSES:        
Selling and marketing expenses 49,076 54,018 131,802 113,442
Salaries, wages and related benefits 230,916 189,986 433,465 468,562
Stock compensation expense 7,835 260,249 16,335 290,393
Research and development 21,623 6,371 41,918 12,275
Professional fees 176,331 112,762 394,450 302,221
General and administrative expenses 256,291 258,508 527,719 447,514
Total Operating Expense 742,072 881,894 1,545,689 1,634,407
LOSS FROM OPERATIONS (788,032) (668,336) (1,522,906) (1,346,099)
OTHER (EXPENSE) INCOME        
Income from investment in subsidiary 8,782 10,123 40,938
Loss from sale of note receivable (26,782) (41,782)
Interest expense (13,028) (7,575) (25,465) (21,943)
Interest and other income 3,177 16,264 9,158 23,202
Total Other (Expense) Income (36,633) 17,471 (47,966) 42,197
NET LOSS $ (824,665) $ (650,865) $ (1,570,872) $ (1,303,902)
NET LOSS PER COMMON SHARE        
Basic $ (0.06) $ (0.06) $ (0.12) $ (0.12)
Diluted $ (0.06) $ (0.06) $ (0.12) $ (0.12)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic 13,565,122 10,963,268 13,502,764 10,907,579
Diluted 13,565,122 10,963,268 13,502,764 10,907,579
v3.24.2.u1
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash $ 71,869 $ 527,462
Accounts receivable, net of allowance for credit losses of $248,919 and $150,300 at June 30, 2024 and December 31, 2023, respectively 100,425 209,057
Inventory, net 751,158 849,764
Prepaid expenses 17,957 63,538
Current portion of note receivable 50,000
Total Current Assets 941,409 1,699,821
Operating lease right-of-use assets 727,814 845,563
Property, plant and equipment, net 385,844 424,103
Note receivable, non-current 291,782
Non-marketable equity investment in subsidiary 263,959 253,835
Total Assets 2,319,026 3,515,104
CURRENT LIABILITIES:    
Accrued expenses and other current liabilities 339,728 245,398
Current portion of finance leases 12,396 24,194
Advances from related parties 42,887 42,887
Current portion of operating lease liabilities 174,181 161,905
Total Current Liabilities 1,746,482 1,244,852
Operating lease liabilities, net of current portion 456,465 560,514
Total Liabilities 2,351,325 2,205,366
Commitments and Contingencies (See Note 8)
STOCKHOLDERS’ (DEFICIT) EQUITY:    
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding
Common stock: $0.0001 par value, 30,000,000 shares authorized; 13,708,676 and 13,425,342 issued and outstanding at June 30, 2024 and December 31, 2023, respectively 1,371 1,342
Additional paid-in capital 16,539,674 16,310,868
Accumulated deficit (16,573,344) (15,002,472)
Total Stockholders’ (Deficit) Equity (32,299) 1,309,738
Total Liabilities and Stockholders’ Equity 2,319,026 3,515,104
Nonrelated Party [Member]    
CURRENT LIABILITIES:    
Accounts payable 634,663 593,338
Current portion of notes payable 400,000 121,610
Notes Payable - net of current portion 148,378 375,000
Related Party [Member]    
CURRENT LIABILITIES:    
Accounts payable 117,627 55,520
Current portion of notes payable 25,000
Notes Payable - net of current portion $ 25,000
v3.24.2.u1
Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Net of allowance for credit losses $ 248,919 $ 150,300
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 100,000 100,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 13,708,676 13,425,342
Common stock, shares outstanding 13,708,676 13,425,342
v3.24.2.u1
Condensed Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) - USD ($)
Common Stock [Member]
Common Class A [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 1,072 $ 13,763,143 $ (12,146,753) $ 1,617,462
Balance, shares at Dec. 31, 2022 10,722,431      
Common stock issued for cash, net of issuance costs $ 32 439,539 439,571
Common stock issued for cash, net of issuance costs, shares 328,800      
Restricted stock issued for services $ 8 4,702 4,710
Stock-based compensation 285,683 285,683
Net loss (1,303,902) (1,303,902)
Stock issued for services $ 5 65,995 66,000
Stock issued for services, shares 52,800      
Warrants and options on private placement 10,761 10,761
Restricted stock issued for services, shares 76,922      
Balance at Jun. 30, 2023 $ 1,117 14,569,823 (13,450,655) 1,120,285
Balance, shares at Jun. 30, 2023 11,180,953      
Balance at Mar. 31, 2023 $ 1,084 13,954,274 (12,799,790) 1,155,568
Balance, shares at Mar. 31, 2023 10,850,037      
Common stock issued for cash, net of issuance costs $ 25 346,039 346,064
Common stock issued for cash, net of issuance costs, shares 253,994      
Stock-based compensation 255,539 255,539
Net loss (650,865) (650,865)
Stock issued for services $ 8 4,702 4,710
Stock issued for services, shares 76,922      
Warrants and options on private placement 9,269 9,269
Balance at Jun. 30, 2023 $ 1,117 14,569,823 (13,450,655) 1,120,285
Balance, shares at Jun. 30, 2023 11,180,953      
Balance at Dec. 31, 2023 $ 1,342 16,310,868 (15,002,472) 1,309,738
Balance, shares at Dec. 31, 2023 13,425,342      
Common stock issued for cash, net of issuance costs $ 29 212,471 212,500
Common stock issued for cash, net of issuance costs, shares 283,334      
Restricted stock issued for services 11,382 11,382
Stock-based compensation 4,953 4,953
Net loss (1,570,872) (1,570,872)
Balance at Jun. 30, 2024 $ 1,371 16,539,674 (16,573,344) (32,299)
Balance, shares at Jun. 30, 2024 13,708,676      
Balance at Mar. 31, 2024 $ 1,349 16,374,361 (15,748,679) 627,031
Balance, shares at Mar. 31, 2024 13,498,676      
Common stock issued for cash, net of issuance costs $ 22 157,478 157,500
Common stock issued for cash, net of issuance costs, shares 210,000      
Restricted stock issued for services 5,691 5,691
Stock-based compensation 2,144 2,144
Net loss (824,665) (824,665)
Balance at Jun. 30, 2024 $ 1,371 $ 16,539,674 $ (16,573,344) $ (32,299)
Balance, shares at Jun. 30, 2024 13,708,676      
v3.24.2.u1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (1,570,872) $ (1,303,902)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Change in inventory obsolescence reserve 80,279 (3,680)
Depreciation and amortization expense 53,817 56,265
Bad debt expense 98,619 47,997
Stock issued for services 11,382 70,710
Stock-based compensation 4,953 285,683
Income from investment in subsidiary (10,123) (40,938)
Change in operating assets and liabilities:    
Accounts receivable 10,014 (53,181)
Inventory 18,327 74,190
Prepaid expenses and contract assets 45,581 109,794
Accounts payable 83,104 (47,650)
Accounts payable - related party 62,107 13,498
Operating lease liabilities 25,977 14,190
Accrued expenses 94,330 51,629
Total adjustments 578,367 578,507
NET CASH USED BY OPERATING ACTIVITIES (992,505) (725,395)
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds from note receivable 300,000 20,000
Purchases of property and equipment (15,558) (2,829)
NET CASH PROVIDED BY INVESTING ACTIVITIES 284,442 17,171
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from sale of common stock and warrants 212,500 445,000
Proceeds from issuance of convertible debt and warrants 50,000 50,000
Repayment of bank loans (1,630)
Repayment of finance leases (10,030) (24,556)
NET CASH PROVIDED BY FINANCING ACTIVITIES 252,470 468,814
NET DECREASE IN CASH (455,593) (239,410)
CASH, beginning of period 527,462 259,223
CASH, end of period 71,869 19,813
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the period for interest $ 1,012 $ 21,943
v3.24.2.u1
ORGANIZATION AND BASIS OF PRESENTATION
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

 

Organization

 

Nano Magic Inc. (“we”, “us”, “our”, “Nano Magic” or the “Company”), a Delaware corporation, develops and sells a portfolio of nano-layer coatings, nano-based cleaners, and nano-composite products based on its proprietary technology.

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information. Accordingly, they do not include all the information and disclosures required by US GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed financial statements of the Company as of June 30, 2024 and for the three and six months ended June 30, 2024 and 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the operating results for the full year ending December 31, 2024 or any other period. The balance sheet at December 31, 2023 has been derived from the audited financial statement at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and related disclosures of the Company as of December 31, 2023 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 3, 2024.

 

Going Concern

 

These unaudited financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the unaudited financial statements, the Company had losses from operations and net cash used by operations of $1,522,906 and $992,505 for the six months ended June 30, 2024 and a loss from operations of $1,346,099 and net cash used by operations of $725,395 for the six months ended June 30, 2023. Moreover, at June 30, 2024, the Company had a working capital deficit of $(805,072) as compared to positive working capital of $454,969 at December 31, 2023. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited financial statements are issued. Management cannot provide assurance that the Company will ultimately achieve profitable operations, become cash flow positive or raise additional capital. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. They do not include any adjustments related to the recoverability and/or classification of the recorded asset amounts and/or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Reclassifications

 

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period. These reclassifications had no effect on the previously reported net loss.

 

v3.24.2.u1
INVENTORY
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 2 – INVENTORY

 

At June 30, 2024 and December 31, 2023, inventory consisted of the following:

 

   June 30, 2024   December 31, 2023 
Raw materials  $677,239   $648,537 
Work-in-progress   219,856    235,811 
Finished goods   265,847    296,921 
Inventory, gross   1,162,942    1,181,269 
Less: reserve for obsolescence   (411,784)   (331,505)
Inventory, net  $751,158   $849,764 

 

 

v3.24.2.u1
INVESTMENT IN SUBSIDIARY
6 Months Ended
Jun. 30, 2024
Investments, All Other Investments [Abstract]  
INVESTMENT IN SUBSIDIARY

NOTE 3 – INVESTMENT IN SUBSIDIARY

 

For the three- and six-month periods ended June 30, 2024, we sold portions of the note receivable from ANI to various parties for total cash proceeds of $100,000 and $300,000, respectively, incurring a loss on the sale of the note of $15,000 and $41,782, respectively. The losses were recorded in Other Expense in the statement of operations. As a result, at June 30, 2024, the note receivable had a balance of $0 as compared to $341,782 at December 31, 2023; $0 was included in current assets at June 30, 2024 with $50,000 included in current assets at December 31, 2023.

 

The Company is accounting for its 30% ownership interest in ANI by the equity method of accounting under which the Company’s share of the net income (loss) of ANI is recognized as income (loss) in the Company’s statement of operations. Any dividends received from ANI as well as periodic losses for the Company’s 30% share will be treated as a reduction of the investment account. Periodic income will be treated as an increase in the investment account. At June 30, 2024 and December 31, 2023, the non-marketable investment in subsidiary was $263,959 and $253,835, included in non-current assets. For the three- and six-month periods ended June 30, 2024, the Company recorded income from the investment in the subsidiary of $0 and $10,123 respectively. For the three and six-month periods ended June 30, 2023, the Company recorded income of $8,782 and $40,938, respectively. See Note 9, Subsequent Events, describing the sale of a part of our interest in ANI.

 

v3.24.2.u1
NOTES PAYABLE AND FINANCE LEASE
6 Months Ended
Jun. 30, 2024
Notes Payable And Finance Lease  
NOTES PAYABLE AND FINANCE LEASE

NOTE 4 – NOTES PAYABLE AND FINANCE LEASE

 

Notes Payable

 

On January 7, 2022, the Company sold to one investor a $100,000 convertible note due March 31, 2025. On January 26, 2022, and January 31, 2022, the Company sold two $50,000 convertible notes to two different investors. The $50,000 notes are due March 31, 2025 and March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On July 27, 2022, the Company sold two convertible notes, one for $50,000 and one for $25,000, both due on March 31, 2025. The $25,000 note is to Mr. Ron Berman, a Related Party. On August 22, 2022, the Company sold a $25,000 convertible promissory note due March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On October 26, 2022, the Company sold to an investor a $25,000 convertible promissory note due October 31, 2023. Issued at face value, the note bears interest at 8% per annum, payable semi-annually in cash. The note is convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share. On October 18, 2023, the Company and the holder extended the maturity date of the note to October 31, 2024.

 

On December 18, 2022, the Company issued a convertible promissory note for $50,000 that is secured by certain payroll tax credits the Company is entitled to receive under the Employee Retention Tax Credit program. The note was issued at face value and bears interest at 8% per annum, payable at maturity on June 18, 2024. The note can be converted to common stock at any time at the option of the holders at a conversion price of $1.75 per share at which point accrued interest will be paid in cash. At June 30, 2024, the note remains unpaid.

 

On June 14, 2023, the Company issued a convertible, secured note and warrants to purchase 10,000 shares of the Company’s common stock for $50,000 with the same terms as the one issued on December 18, 2022. The warrants were recorded as a debt discount on the date of issuances for a total value of $5,333. The balance at June 30, 2024 and December 31, 2023 of the debt discount was $1,622 and $3,390, respectively.

 

On July 24, 2023, the Company issued at face value a convertible note in the original principal amount of $50,000. The note is due on July 24, 2025, bears interest at 8% per annum and is convertible at $1.25 per share.

 

On November 2, 2023, the Company issued at face value a convertible note in the original principal amount of $50,000. The note is due on November 2, 2025, bears interest at 8% per annum and is convertible at $1.25 per share.

 

On June 10, 2024, the Company issued a $50,000 promissory note to an investor. The note bears interest at 1% per month and all principal and interest is payable 120 days from the date of issuance. The note is secured by two purchase orders from a large customer.

 

At June 30, 2024 and at December 31, 2023, we had outstanding convertible notes aggregating $575,000 and $525,000 in principal amount. The convertible promissory notes have not been included in diluted earnings per share as they would be anti-dilutive.

 

 

Finance Lease

 

In December 2020, the company entered into a finance lease for production equipment. We financed $85,000 over a period of 48 months with monthly payments of $2,135 during that time. At June 30, 2024 and December 31, 2024, the balances on the finance lease were $12,396 and $24,194, respectively. These balances are included in current liabilities on the balance sheet.

 

v3.24.2.u1
OPERATING LEASE
6 Months Ended
Jun. 30, 2024
Operating Lease  
OPERATING LEASE

NOTE 5 – OPERATING LEASE

 

Effective May 31, 2020, we entered into a lease with a related party for a 29,220 square foot building in Madison Heights, Michigan. The occupancy and rent commencement date was October 1, 2020. The lease has an initial term of seven years with a renewal option at the end of the initial term for an additional 3-year term, and a second renewal option thereafter for an additional 5-year term. The renewal term is not included in the calculation of the operating lease liability. As the sole tenant, we are responsible for all taxes, ordinary maintenance, snow removal and other ordinary operating expenses. Rent is $6.50 per square foot, increasing by $0.25 per year. During the first three years we had the right to buy up to a 49% interest in Magic Research LLC for a price equal to 49% of the contributions received from other members. This right has now expired as we did not exercise the option. See Note 7, Stockholders’ Equity, for a description of warrants issued to the owners of Magic Research LLC in connection with this lease. The fair value of these warrants totaling $311,718 were recorded as initial direct costs of obtaining the lease and are included in right-of-use assets on the accompanying balance sheet. See Note 6, Related Party Transactions, for information about roles in management and economic participation by our CEO and several other directors in the landlord.

 

In February 2023, we reached an agreement with the landlord of our Michigan facility to accept $66,000 worth of our common stock at a price of $1.25 per share as partial payment of rent for the six-month period from October 2022 through March 2023. During that period, we paid cash of $8,056 per month, effectively a cash rent reduction of $10,983 per month. In May 2023, we reached a further agreement with the landlord under which we pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $0.75 per share. We have the option to continue to use stock to pay a portion of the rent through 2024.

 

For operating leases, we calculated ROU assets and lease liabilities based on the present value of the remaining lease payments as of the date of adoption using the IBR as of that date. The ROU Asset was $727,814 at June 30, 2024 and $845,563 at December 31, 2023. The operating lease liability was $630,646 at June 30, 2024 and $722,419 at December 31, 2023.

 

v3.24.2.u1
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

At June 30, 2024 and at December 31, 2023, accounts payable – related parties totaled $117,627 and $55,520, respectively, and advances from related parties totaled $42,887 on both dates. These balances are presented separately in current liabilities on the accompanying balance sheets. These balances consist of amounts owed to directors and officers as well as to the landlord controlled by two of the Company’s directors.

 

 

See Note 9, Subsequent Events, regarding options granted to, among others, officers and certain directors.

 

Mr. Ron Berman and Mr. Tom Berman are the managers of the limited liability company that is the manager of PEN Comeback, LLC, PEN Comeback 2, LLC, Magic Growth, LLP, Magic Growth 2 LLC and Magic Growth 3 LLC. These five limited liability companies purchased shares of common stock and derivative securities from us in 2018, 2019, 2020, 2021 and 2022.

 

In addition, Mr. Tom Berman and Mr. Ron Berman are two of three individuals who share voting power of the sole manager of the limited liability company that is our landlord in Michigan. Together, Tom and Ron Berman hold, in the aggregate, a 5% economic interest in the landlord entity. Another director, Miles Gatland, owns a 12.5% interest in the Michigan landlord and he is a co-guarantor on the debt of that limited liability company. See Note 7, Stockholder’s Equity regarding the issuance of stock in partial satisfaction of unpaid rent. At June 30, 2024 and at December 31, 2023, rents accrued and unpaid totaled $93,627 and $30,141, respectively, which are included in related parties accounts payable on the balance sheet.

 

v3.24.2.u1
STOCKHOLDERS’ EQUITY
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Description of Preferred and Common Stock

 

Preferred Stock

 

The preferred stock may be issued in one or more series. The Company’s board of directors are authorized to issue the shares of preferred stock in such series and to fix from time to time before issuance thereof the number of shares to be included in any such series and the designation, powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, of such series.

 

Common Stock

 

The rights of each share of common are the same with respect to dividends, distributions and rights upon liquidation. Holders of common stock each have one vote per share in the election of directors and other matters submitted to a vote of the stockholders.

 

Issuances of Common Stock

 

Common Stock Issued for Services

 

In February 2023, we reached an agreement with the landlord of our Michigan facility to accept 52,800 shares of our common stock at a price of $1.25 per share as partial payment of rent for the six-month period from October 2022 through March 2023. Those shares were issued in March, 2023. In May 2023, we reached a further agreement with the landlord that calls for us to pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $0.75 per share. We have the option to continue to use stock to pay a portion of the rent through 2024. The landlord is a Related Party.

 

On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services. The shares are subject to forfeiture until vested. So long as the consulting services agreement remains in effect 4,273 shares vested in May for prior service, and another 4,273 shares vest at the end of May and each calendar month thereafter, with 4,277 shares vesting in December 2023. During 2024, 3,205 shares will vest at the end of each month, with 3,206 shares vesting at the end of December 2024.

 

Sales of Common Stock and Derivative Equity Securities

 

During the quarter ended June 30, 2024, the Company sold 210,000 shares of common stock for proceeds of $157,500. During the six-months ended June 30, 2024, the Company sold 283,334 shares of common stock for proceeds of $212,500.

 

 

During the quarter ended June 30, 2023, the Company sold 253,994 shares of common stock for proceeds of $346,064 and warrants to purchase up to 196,813 shares of common stock for proceeds of $4,136. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. During the six-months ended June 30, 2023, the Company sold 328,800 shares of common stock for proceeds of $439,571 and warrants to purchase up to 271,439 shares of common stock for proceeds of $5,428. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. Also, during the three-months ended June 30, 2023, the Company sold 10,000 warrants in connection with the issuance of a convertible note payable of $50,000 as disclosed in Note 5. In accordance with ASC 470, 11% of the value of the total convertible note payable was allocated to the warrants.

 

Stock Options

 

Stock options to purchase common stock outstanding at June 30, 2024 include those described below. No options were exercised during the period. No options have been included in diluted earnings per share as they would be anti-dilutive.

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
  

Aggregate

Intrinsic

Value

 
Outstanding December 31, 2023   2,270,483   $0.67    2.72   $76,725 
Exercised   -    -    -    - 
Issued   -    -    -    - 
Expired & forfeited   (55,297)  $0.65    -    - 
Outstanding June 30, 2024   2,215,186   $0.67    3.41   $348,088 
                     
Exercisable June 30, 2024   2,201,545   $0.67    3.41   $346,276 

 

   June 30, 2024   December 31, 2023 
Stock options   2,215,186    2,270,483 
Stock warrants   7,525,265    7,525,265 

Convertible debt (on an as-converted basis)

   

362,738

    

349,824

 
Total   10,103,189    10,145,572 

 

Warrants

 

As of June 30, 2024, there were outstanding and exercisable warrants to purchase 7,525,265 shares of common stock. The outstanding warrants have a weighted average exercise price of $1.72 per share and a weighted average remaining contractual term of 34.7 months. As of June 30, 2024 and December 31, 2023, there was no intrinsic value for the warrants. No warrants have been included in diluted earnings per share as they would be anti-dilutive.

 

2021 Equity Incentive Plan

 

On March 2, 2021, our Board adopted the 2021 Nano Magic 2021 Equity Incentive Plan (the “Plan”) to allow equity compensation for those who provide services to the Company and to encourage ownership in the Company by personnel whose service to the Company is important to its continued progress, to encourage recipients to act as owners and thereby in the stockholders’ interest and to enable recipients to share in the Company’s success.

 

On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan. On May 30, 2023 the Board granted an additional 175,071 options under the 2021 Equity Plan to employees and a consultant. All options are at an exercise price of $0.65.

 

See Note 9, Subsequent Events, regarding additional options granted under the 2021 Equity Plan.

 

 

Other Options

 

On April 12, 2023, the Company issued an additional 30,000 options to Tom J. Berman, our President. On May 30, 2023, the Board granted 384,228 options to officers and to a consultant who is also a director.

 

See Note 9, Subsequent Events, regarding options granted to officers and certain directors.

 

v3.24.2.u1
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may be, from time to time, subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. As of June 30, 2024 we were not a defendant in any proceedings. Our policy is to accrue costs for contingent liabilities, including legal proceedings or unasserted claims that may result in legal proceedings, when a liability is probable and the amount can be reasonably estimated. As of June 30, 2024 and December 31, 2023, the Company has not accrued any amount for litigation contingencies.

 

v3.24.2.u1
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

On July 18, 2024, the Company sold an aggregate of 166,666 shares of common stock for proceeds of $125,000 to two different investors.

 

On July 29,2024, the Board authorized the sale of a portion of the Company’s interest in Applied Nanotech, Inc. The sale was consummated on the same day; the Company received $100,000 in cash and its interest in Applied Nanotech was reduced from 30% to 25%.

 

On July 29, 2024, The Company granted 411,268 options to employees, contractors and consultants under the 2021 Equity Plan and increased amounts available for grant by that number. All options entitle the holder to purchase shares at a strike price of $0.31 and expire five years from date of grant.

 

On July 29, 2024, the Company also granted options to our President & CEO, Tom Berman: 250,000 vesting on date of grant, 250,000 vesting on December 31,2024, and 1,000,000 that will vest if he earns a Profit Bonus under his contract and the Board elects to pay some or all of that bonus with options. On that same day, the Board granted 60,000 options to our Chief Financial Officer, Leandro Vera, 60,000 options to director Ronald Berman, 30,000 options to director Scott Rickert and 30,000 options to director and Secretary Jeanne Rickert. These options were 50% vested on date of grant and will vest ratably over the remainder of 2024. Options to officers and directors were not issued under the Plan, but these options also entitle the holder to purchase shares at a strike price of $0.31 and expire five years from date of grant.

 

On August 5, 2024, the Company sold 133,333 shares for proceeds of $100,000.

v3.24.2.u1
INVENTORY (Tables)
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORY

At June 30, 2024 and December 31, 2023, inventory consisted of the following:

 

   June 30, 2024   December 31, 2023 
Raw materials  $677,239   $648,537 
Work-in-progress   219,856    235,811 
Finished goods   265,847    296,921 
Inventory, gross   1,162,942    1,181,269 
Less: reserve for obsolescence   (411,784)   (331,505)
Inventory, net  $751,158   $849,764 
v3.24.2.u1
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
SCHEDULE OF STOCK OPTION PLAN ACTIVITY

Stock options to purchase common stock outstanding at June 30, 2024 include those described below. No options were exercised during the period. No options have been included in diluted earnings per share as they would be anti-dilutive.

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
  

Aggregate

Intrinsic

Value

 
Outstanding December 31, 2023   2,270,483   $0.67    2.72   $76,725 
Exercised   -    -    -    - 
Issued   -    -    -    - 
Expired & forfeited   (55,297)  $0.65    -    - 
Outstanding June 30, 2024   2,215,186   $0.67    3.41   $348,088 
                     
Exercisable June 30, 2024   2,201,545   $0.67    3.41   $346,276 
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS SHARE
   June 30, 2024   December 31, 2023 
Stock options   2,215,186    2,270,483 
Stock warrants   7,525,265    7,525,265 

Convertible debt (on an as-converted basis)

   

362,738

    

349,824

 
Total   10,103,189    10,145,572 
v3.24.2.u1
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Loss from operations $ 788,032 $ 668,336 $ 1,522,906 $ 1,346,099  
Net cash used in operating activities     992,505 $ 725,395  
Working capital surplus (deficit) $ (805,072)   $ (805,072)   $ 454,969
v3.24.2.u1
SCHEDULE OF INVENTORY (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 677,239 $ 648,537
Work-in-progress 219,856 235,811
Finished goods 265,847 296,921
Inventory, gross 1,162,942 1,181,269
Less: reserve for obsolescence (411,784) (331,505)
Inventory, net $ 751,158 $ 849,764
v3.24.2.u1
INVESTMENT IN SUBSIDIARY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Related Party Transaction [Line Items]          
Proceeds from note receivable $ 100,000   $ 300,000 $ 20,000  
Loss on sale of note 15,000   41,782    
Note receivable outstanding 0   0   $ 341,782
Current portion of note receivable     50,000
Non-marketable equity investment 263,959   263,959   $ 253,835
Income (loss) from investment in subsidiary $ 8,782 $ 10,123 $ 40,938  
Applied Nanotech, Inc. [Member]          
Related Party Transaction [Line Items]          
Sale of interest in subsidiary     30.00%    
v3.24.2.u1
NOTES PAYABLE AND FINANCE LEASE (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Jun. 10, 2024
Nov. 02, 2023
Oct. 18, 2023
Jul. 24, 2023
Jun. 14, 2023
Oct. 26, 2022
Aug. 22, 2022
Jan. 31, 2022
Jan. 26, 2022
Jan. 07, 2022
Dec. 18, 2022
Dec. 31, 2020
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Jul. 27, 2022
Feb. 14, 2022
Short-Term Debt [Line Items]                                  
Proceeds from convertible debt                         $ 50,000 $ 50,000      
Proceeds from issuance of common stock                         212,500 $ 445,000      
Debt discount                         1,622   $ 3,390    
Current portion of finance leases                         12,396   24,194    
Production Equipment [Member]                                  
Short-Term Debt [Line Items]                                  
Finance lease, liability                       $ 85,000          
Lessee, finance lease, term of contract                       48 months          
Finance lease, principal payments                       $ 2,135          
Convertible Promissory Notes [Member]                                  
Short-Term Debt [Line Items]                                  
Debt maturity date                     Jun. 18, 2024            
Debt instrument conversion price   $ 1.25   $ 1.25             $ 1.75            
Proceeds from convertible debt $ 50,000 $ 50,000   $ 50,000             $ 50,000            
Debt instrument, interest rate 1.00% 8.00%   8.00%             8.00%            
Proceeds from secured debt         $ 10,000                        
Proceeds from issuance of common stock         50,000                        
Proceeds from issuance of debt discount         $ 5,333                        
Convertible Notes Payable                         $ 575,000   $ 525,000    
Convertible Debt [Member]                                  
Short-Term Debt [Line Items]                                  
Convertible debt             $ 25,000 $ 50,000 $ 50,000 $ 100,000           $ 50,000  
Debt maturity date     Oct. 31, 2024     Oct. 31, 2023 Mar. 31, 2026     Mar. 31, 2025              
Annual payable interest percentage           8.00% 8.00%                    
Debt instrument conversion price           $ 1.75 $ 1.75                    
Proceeds from convertible debt           $ 25,000                      
Convertible Debt One [Member]                                  
Short-Term Debt [Line Items]                                  
Convertible debt                               25,000  
Debt maturity date                 Mar. 31, 2025                
Annual payable interest percentage                 8.00%                
Debt instrument conversion price                 $ 1.75                
Convertible Debt One [Member] | Related Party [Member]                                  
Short-Term Debt [Line Items]                                  
Convertible debt                               $ 25,000  
Convertible Debt Two [Member]                                  
Short-Term Debt [Line Items]                                  
Debt maturity date               Mar. 31, 2026                  
Annual payable interest percentage                 8.00%                
Debt instrument conversion price               $ 1.75                  
Convertible Debt Three [Member]                                  
Short-Term Debt [Line Items]                                  
Annual payable interest percentage               8.00%                  
Debt instrument conversion price                                 $ 1.75
v3.24.2.u1
OPERATING LEASE (Details Narrative)
1 Months Ended
May 31, 2020
USD ($)
ft²
Feb. 28, 2023
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
May 31, 2023
$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Lease with related party | ft² 29,220        
Lessee operating lease description The lease has an initial term of seven years with a renewal option at the end of the initial term for an additional 3-year term, and a second renewal option thereafter for an additional 5-year term. The renewal term is not included in the calculation of the operating lease liability. As the sole tenant, we are responsible for all taxes, ordinary maintenance, snow removal and other ordinary operating expenses. Rent is $6.50 per square foot, increasing by $0.25 per year. During the first three years we had the right to buy up to a 49% interest in Magic Research LLC for a price equal to 49% of the contributions received from other members.        
Fair value of warrants $ 311,718        
Cash     $ 71,869 $ 527,462  
Right-of-use assets     727,814 845,563  
Operating lease liabilities     $ 630,646 $ 722,419  
Land Lord Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued for services, shares | shares   66,000      
Shares issued, price per share | $ / shares   $ 1.25     $ 0.75
Cash   $ 8,056      
Payments for rent   $ 10,983      
Share price | $ / shares   $ 0.75      
v3.24.2.u1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Related Party Transaction [Line Items]    
Advances from related parties $ 42,887 $ 42,887
Accrued Rent $ 93,627 30,141
Tom Berman and Ron Berman [Member]    
Related Party Transaction [Line Items]    
[custom:EconomicInterestPercentage] 5.00%  
Miles Gatland [Member]    
Related Party Transaction [Line Items]    
[custom:EconomicInterestPercentage] 12.50%  
Related Party [Member]    
Related Party Transaction [Line Items]    
Accounts payable - related parties $ 117,627 $ 55,520
v3.24.2.u1
SCHEDULE OF STOCK OPTION PLAN ACTIVITY (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Equity [Abstract]    
Number of Options, Outstanding 2,270,483  
Weighted Average Exercise Price, Outstanding $ 0.67  
Weighted Average Remaining Contractual Terms (Years), Outstanding 3 years 4 months 28 days 2 years 8 months 19 days
Aggregate Intrinsic Value, Outstanding $ 76,725  
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Number of Options, Issued  
Weighted Average Exercise Price, Issued  
Number of Options, Forfeited and expired (55,297)  
Weighted Average Exercise Price, Forfeited and expired $ 0.65  
Number of Options, Outstanding 2,215,186 2,270,483
Weighted Average Exercise Price, Outstanding $ 0.67 $ 0.67
Aggregate Intrinsic Value, Outstanding $ 348,088 $ 76,725
Number of Options, Exercisable 2,201,545  
Weighted Average Exercise Price, Exercisable $ 0.67  
Weighted Average Remaining Contractual Terms (Years), Exercisable 3 years 4 months 28 days  
Aggregate Intrinsic Value, Exercisable $ 346,276  
v3.24.2.u1
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS SHARE (Details) - shares
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 10,103,189 10,145,572
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,215,186 2,270,483
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 7,525,265 7,525,265
Convertible Debt Securities [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 362,738 349,824
v3.24.2.u1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 30, 2023
Apr. 12, 2023
Feb. 28, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
May 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock, voting rights           The rights of each share of common are the same with respect to dividends, distributions and rights upon liquidation. Holders of common stock each have one vote per share in the election of directors and other matters submitted to a vote of the stockholders      
Number of shares sold       210,000   283,334      
Number of shares sold, value       $ 157,500   $ 212,500      
Number of warrants issued         10,000   10,000    
Convertible note payable           $ 50,000 $ 50,000    
Weighted average remaining contractual term           3 years 4 months 28 days   2 years 8 months 19 days  
Options issued                
Weighted average exercise price issued                
Tom J Berman [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Options issued   30,000              
Officers [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Options issued 384,228                
2021 Equity Incentive Plan [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Options issued 175,071 47,610              
Weighted average exercise price issued $ 0.65                
Common Stock and Derivative Equity Securities [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares sold         253,994   328,800    
Number of shares sold, value         $ 346,064   $ 439,571    
Number of warrants purchase         196,813        
Proceeds from issuance of warrants         $ 4,136   $ 5,428    
Warrant exercise price per share         $ 1.75   $ 1.75    
Number of warrants issued         271,439   271,439    
Warrant [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Warrant exercise price per share       $ 1.72   $ 1.72      
Class of warrant or right, outstanding       7,525,265   7,525,265      
Weighted average remaining contractual term           34 months 21 days      
Restricted Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock issued for services, shares 76,922                
Restricted Stock [Member] | Vested In May [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock vested, shares 4,273                
Restricted Stock [Member] | Vest At End Of May [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock vested, shares 4,273                
Restricted Stock [Member] | Vesting At End Of December 31, 2023 [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock vested, shares 4,277                
Restricted Stock [Member] | Vest At End Of Each Month In December 31, 2024 [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock vested, shares 3,205                
Restricted Stock [Member] | Vesting At End Of Each Month In December 31, 2024 [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock vested, shares 3,206                
Land Lord Agreement [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock issued for services, shares     52,800            
Shares issued, price per share     $ 1.25           $ 0.75
Partial payment, description     partial payment of rent for the six-month period from October 2022 through March 2023. Those shares were issued in March, 2023            
v3.24.2.u1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 05, 2024
Jul. 29, 2024
Jul. 18, 2024
Jun. 30, 2024
Jun. 30, 2024
Jul. 28, 2024
Dec. 31, 2023
Subsequent Event [Line Items]              
Number of shares sold       210,000 283,334    
Number of shares sold, value       $ 157,500 $ 212,500    
Cash       $ 71,869 $ 71,869   $ 527,462
Number of stock options, granted            
Subsequent Event [Member]              
Subsequent Event [Line Items]              
Number of shares sold 133,333   166,666        
Number of shares sold, value $ 100,000   $ 125,000        
Cash   $ 100,000          
Option strike price   $ 0.31          
Share based compensation vesting percentage   50.00%          
Subsequent Event [Member] | Tom Berman [Member]              
Subsequent Event [Line Items]              
Number of stock options, granted   250,000          
Number of stock options, expected to vest   1,000,000          
Subsequent Event [Member] | Tom Berman [Member] | December 31, 2024 [Member]              
Subsequent Event [Line Items]              
Number of stock options, vested   250,000          
Subsequent Event [Member] | Leandro Vera [Member]              
Subsequent Event [Line Items]              
Number of stock options, granted   60,000          
Subsequent Event [Member] | Ronald Berman [Member]              
Subsequent Event [Line Items]              
Number of stock options, granted   60,000          
Subsequent Event [Member] | Scott Rickert [Member]              
Subsequent Event [Line Items]              
Number of stock options, granted   30,000          
Subsequent Event [Member] | Jeanne Rickert [Member]              
Subsequent Event [Line Items]              
Number of stock options, granted   30,000          
Subsequent Event [Member] | 2021 Equity Plan [Member]              
Subsequent Event [Line Items]              
Number of stock options, granted   411,268          
Option strike price   $ 0.31          
Expiration period   5 years          
Subsequent Event [Member] | Applied Nanotech, Inc. [Member]              
Subsequent Event [Line Items]              
Ownership percentage   25.00%       30.00%  

Nano Magic (QB) (USOTC:NMGX)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Nano Magic (QB).
Nano Magic (QB) (USOTC:NMGX)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Nano Magic (QB).